Scrip Podcasts
Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.
2 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Scrip Podcasts-fællesskabet!